Skip to main content
Fig. 2 | Acta Neuropathologica Communications

Fig. 2

From: Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups

Fig. 2

Clinicopathologic features of GBM-O cases and results of targeted Fluidigm DNA sequencing. a Case details including previously obtained FISH (EGFR, 1p/19q) and IDH1 R132H immunohistochemistry results. *prior diagnosis was fibrillary astrocytoma, grade II b Nonsynonymous mutations were detected in 5/8 cases (12 missense, 1 nonsense). Numerals in boxes indicate number of mutations if more than one

Back to article page